Sartorius Aktiengesellscha Company Top Insiders
SARTF Stock | USD 182.98 9.77 5.07% |
Sartorius Aktiengesellscha employs about 16 K people. The company is managed by 10 executives with a total tenure of roughly 40 years, averaging almost 4.0 years of service per executive, having 1603.8 employees per reported executive. Examination of Sartorius Aktiengesellscha's management performance can provide insight into the company performance.
Joachim Kreuzburg Chairman Chairman of the Executive Board, CEO, Executive for Labor Relations |
Petra Kirchhoff President Member of the Supervisory Board, Vice President of Corporate Communications & Investor Relations |
Sartorius |
Sartorius Aktiengesellscha Management Team Effectiveness
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3386 %, meaning that it generated $0.3386 on every $100 dollars invested by stockholders. Sartorius Aktiengesellscha's management efficiency ratios could be used to measure how well Sartorius Aktiengesellscha manages its routine affairs as well as how well it operates its assets and liabilities.Sartorius Aktiengesellscha Workforce Comparison
Sartorius Aktiengesellschaft is currently regarded as top stock in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is at this time estimated at about 226,943. Sartorius Aktiengesellscha holds roughly 16,038 in number of employees claiming about 7% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27. Sartorius Aktiengesellscha Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sartorius Aktiengesellscha Price Series Summation is a cross summation of Sartorius Aktiengesellscha price series and its benchmark/peer.
Sartorius Aktiengesellscha Notable Stakeholders
A Sartorius Aktiengesellscha stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sartorius Aktiengesellscha often face trade-offs trying to please all of them. Sartorius Aktiengesellscha's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sartorius Aktiengesellscha's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Joachim Kreuzburg | Chairman of the Executive Board, CEO, Executive for Labor Relations | Profile | |
Petra Kirchhoff | Member of the Supervisory Board, Vice President of Corporate Communications & Investor Relations | Profile | |
Rainer Lehmann | CFO, Member of the Executive Board | Profile | |
Rene Faber | Member of the Executive Board, Head of the Bioprocess Solutions Division | Profile | |
Rashid Maqbool | Head USA | Profile | |
Manfred Werner | Sr Auditing | Profile | |
John MacKay | Member of the Executive Board, Head of the Lab Products & Services Division | Profile | |
Patricia Spannagel | Head Goettingen | Profile | |
Mei Wang | Head China | Profile | |
Manohar Kuppusami | Head India | Profile |
About Sartorius Aktiengesellscha Management Performance
The success or failure of an entity such as Sartorius Aktiengesellscha often depends on how effective the management is. Sartorius Aktiengesellscha management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sartorius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sartorius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. Sartorius operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 13832 people.
Sartorius Aktiengesellscha Workforce Analysis
Traditionally, organizations such as Sartorius Aktiengesellscha use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sartorius Aktiengesellscha within its industry.Sartorius Aktiengesellscha Manpower Efficiency
Return on Sartorius Aktiengesellscha Manpower
Revenue Per Employee | 215.1K | |
Revenue Per Executive | 344.9M | |
Net Income Per Employee | 19.9K | |
Net Income Per Executive | 31.9M | |
Working Capital Per Employee | 17.6K | |
Working Capital Per Executive | 28.2M |
Complementary Tools for Sartorius Pink Sheet analysis
When running Sartorius Aktiengesellscha's price analysis, check to measure Sartorius Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Aktiengesellscha is operating at the current time. Most of Sartorius Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Sartorius Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Aktiengesellscha's price. Additionally, you may evaluate how the addition of Sartorius Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |